EXACT Sciences Corporation


Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation Announces Blue Cross Blue Shield of Rhode Island to Cover Cologuard

EXACT Sciences Corporation (NASDAQ:EXAS) announced that it has entered into an agreement with Blue Cross Blue Shield (BCBS) of Rhode Island, one of the …

Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation Highlights CMS Advisory Panel’s Unanimous Vote to Maintain Medicare Reimbursement Rate for Cologuard®

EXACT Sciences Corporation (NASDAQ:EXAS) announced that the Centers for Medicare and Medicaid Services (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously to …

Canaccord Cuts Price Target For Exact Sciences Corporation; Here’s Why

In a research report published Monday, Canaccord analyst Mark Massaro maintained a Buy rating on shares of Exact Sciences Corporation (NASDAQ:EXAS) with a price target …

Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation Announces Pricing of Public Offering of Common Stock

EXACT Sciences Corporation (NASDAQ:EXAS) announced that Jefferies LLC and Robert W. Baird & Co.

Tuesday Morning Insights: Tesla Motors Inc (TSLA), Shake Shack Inc (SHAK), CytRx Corporation (CYTR), EXACT Sciences Corporation (EXAS)

Tesla Motors Inc (NASDAQ:TSLA) shares fell nearly -5% in pre-market trading after the company received a downgrade from Colin Langan at UBS. The …

Company Update (NASDAQ:EXAS): EXACT Sciences Corporation Announces Agreement to Sell 7,000,000 Common Shares

EXACT Sciences Corporation (NASDAQ:EXAS) announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC and Robert W. Baird & Co.

Canaccord Reiterates Buy on EXACT Sciences Corporation Following 2Q:15 Update

In a research report released today, Canaccord Genuity analyst Mark Massaro reiterated a Buy rating on EXACT Sciences Corporation (NASDAQ:EXAS) with a $32 price target, …

Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation Highlights Cologuard’s(r) Positive Launch Trajectory in Second Quarter 2015

EXACT Sciences Corporation (NASDAQ:EXAS) announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more …

Roth Capital Raises Price Target For Exact Sciences Corporation Following Analyst Day

Roth Capital analyst Chris Lewis weighed in today with a few insights on Exact Sciences Corporation  (NASDAQ:EXAS), after the company held its investor & analyst day on June 25. …

William Blair Reiterates Outperform on EXACT Sciences Corporation Following Investor Day

In a research report issued on Friday, William Blair analyst Brian Weinstein offered some insights EXACT Sciences Corporation (NASDAQ:EXAS) following the company’s first investor day held yesterday. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts